MedCap AB (publ) operates in the Investors sector.
In addition to historical fundamental analyses, the complete report available to purchase compares MedCap AB (publ) with three other
financial institutions in Europe:
sales of 762.70 million Swedish Kronor [US$85.81 million]
of which 100%
was Investment Activities),
Deutsche Beteiligungs AG
(85.21 million Euro [US$91.23 million]
of which 71%
was Private Equity Investments), and
Gimv Investeringsmaatschappij Voor Vlanderen NV
based in Belgium
(103.76 million Euro [US$111.10 million]
of which 36%
was Health & Care).
MedCap AB (publ) reported sales of SEK 816.92 million (US$91.91 million)
April of 2016.
decrease of 4.2%
versus 2015, when the company's sales were SEK 852.75 million.
Contributing to the drop in overall sales was the 8.6% decline
in Unimedic, from SEK 664.76 million to SEK 607.55 million.
However, these declines were partially offset by the increase in sales of
Abilia (up 3.1% to SEK 182.63 million)
Quickels (up 61.3% to SEK 17.55 million)